Dhampur Bio Organics Ltd

Dhampur Bio Organics Ltd has completed the slump sale of its Meerganj Unit, a sugar factory located in Bareilly, Uttar Pradesh, to Forever Global Enterprises Limited. The transaction was finalized on June 18, 2026, with the company receiving a purchase consideration of 305 Crores. The completion involved the execution and registration of the conveyance deed, following the Business Transfer Agreement signed on April 20, 2026. This divestment was previously intimated to the exchanges.

Dhampur Bio Organics Ltd. announced the resignation of Mr. Sarabjit Saini, Unit Head, Meerganj (Vice President - Operations), effective June 15, 2026. The resignation is due to personal reasons. The company has provided the necessary disclosures as per SEBI (LODR) Regulations, 2015, including the reason for change and the cessation date. This management change may impact operational continuity at the Meerganj unit.

Dhampur Bio Organics Ltd announced the resignation of Mrs. Monika Sharma, Vice President - Information Technology, effective June 15, 2026. The resignation is due to personal reasons. The company has provided the necessary disclosures as per SEBI (LODR) Regulations, 2015, including the reason for the change and the cessation date. This marks a change in key management personnel within the IT department.

Dhampur Bio Organics Ltd. has executed a Joint Venture Agreement with Orgonew Private Limited to develop, manufacture, market, distribute, and commercialize phyto bio-active based functional food products. The Joint Venture Company (JVC) will leverage Orgonew's proprietary nano-curcumin coating technology and Dhampur's manufacturing and distribution capabilities. Dhampur Bio Organics will hold a 74% stake in the JVC, with Orgonew holding 26%. The agreement includes a 5-year lock-in period and specific board appointment rights for Dhampur Bio Organics.

Dhampur Bio Organics Ltd announced the resignation of Mr. Rakesh Agarwal from the position of Vice President - Bottling Operations, effective May 31, 2026. The resignation was tendered due to personal reasons, as stated in his resignation letter. The company has provided details as required under Regulation 30 of the Listing Regulations, along with a copy of the resignation letter.

Dhampur Bio Organics Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026. A dividend of ₹1.50 per equity share was recommended, with a record date of July 17, 2026. The board also approved the re-designation of Mr. Gautam Goel as Chairman and CEO, acquisition of Sonitron Chemicals Private Limited, re-appointment of auditors, and other corporate actions, all subject to shareholder approval. The 6th Annual General Meeting is scheduled for July 24, 2026.

Dhampur Bio Organics Ltd's board approved audited financial results for the year ended March 31, 2026, and recommended a dividend of ₹1.50 per share, subject to shareholder approval. The record date for the dividend is set for July 17, 2026. The board also approved the re-designation of Mr. Gautam Goel as Chairman and CEO, acquisition of Sonitron Chemicals Private Limited, and re-appointment of statutory and cost auditors, all subject to shareholder approval. Additionally, the 6th Annual General Meeting will be held on July 24, 2026.

Dhampur Bio Organics Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026, recommending a dividend of ₹1.50 per equity share, subject to shareholder approval. The record date for the dividend is set for July 17, 2026. The board also approved the re-designation of Mr. Gautam Goel as Chairman and CEO, acquisition of Sonitron Chemicals Private Limited, and re-appointment of statutory and cost auditors, all subject to shareholder approval. The 6th Annual General Meeting will be held on July 24, 2026.

Dhampur Bio Organics Ltd's board has fixed July 17, 2026, as the record date for the final dividend of ₹1.50 per equity share of ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval. The board also approved audited financial results for the quarter and year ended March 31, 2026, and other items including amendment of Article of Association, re-designation of Mr. Gautam Goel as Chairman and CEO, revision in remuneration of Ms. Maayashree Goel and Ms. Meerashree Goel, acquisition of Sonitron Chemicals Private Limited, re-appointment of auditors, recommended commission for Non-Executive Directors and convening the 6th Annual General Meeting on July 24, 2026.

The Board of Directors of Dhampur Bio Organics Ltd, in its meeting on May 30, 2026, approved and recommended a dividend of ₹1.50 per equity share of ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval. The record date for the dividend is set for July 17, 2026. The board also approved audited financial results and several other items including amendment of Article of Association, re-designation of Mr. Gautam Goel as Chairman and CEO, revision in remuneration of Ms. Maayashree Goel and Ms. Meerashree Goel, acquisition of Sonitron Chemicals Private Limited, re-appointment of auditors, recommended commission for Non-Executive Directors and proposal to convene 6th AGM on July 24, 2026.